Wolf O. Bechstein

Research interests

Publications

• Chemoradiotherapy Plus Induction or Consolidation Chemotherapy as Total Neoadjuvant Therapy for Patients With Locally Advanced Rectal Cancer

  JAMA Oncology · 2021 · 10.1001/jamaoncol.2021.5445

• mTOR Inhibition Is Most Beneficial After Liver Transplantation for Hepatocellular Carcinoma in Patients With Active Tumors

  Annals of Surgery · 2020 · https://doi.org/10.1097/sla.0000000000004280

• Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2/3 trial

  The Lancet · 2019 · https://doi.org/10.1016/s0140-6736(18)32557-1

• Randomized Phase II Trial of Chemoradiotherapy Plus Induction or Consolidation Chemotherapy as Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer: CAO/ARO/AIO-12

  Journal of Clinical Oncology · 2019 · 10.1200/jco.19.00308

• Toward a Consensus on Centralization in Surgery

  Annals of Surgery · 2018 · https://doi.org/10.1097/sla.0000000000002965

• CONKO-005: Adjuvant Chemotherapy With Gemcitabine Plus Erlotinib Versus Gemcitabine Alone in Patients After R0 Resection of Pancreatic Cancer: A Multicenter Randomized Phase III Trial

  Journal of Clinical Oncology · 2017 · 10.1200/jco.2017.72.6463

• Effect of Neoadjuvant Chemotherapy Followed by Surgical Resection on Survival in Patients With Limited Metastatic Gastric or Gastroesophageal Junction Cancer

  JAMA Oncology · 2017 · 10.1001/jamaoncol.2017.0515

• Local Treatment of Unresectable Colorectal Liver Metastases: Results of a Randomized Phase II Trial

  JNCI Journal of the National Cancer Institute · 2017 · https://doi.org/10.1093/jnci/djx015

• Practical Recommendations for Long-term Management of Modifiable Risks in Kidney and Liver Transplant Recipients

  Transplantation · 2017 · https://doi.org/10.1097/tp.0000000000001651

• Histopathological regression after neoadjuvant docetaxel, oxaliplatin, fluorouracil, and leucovorin versus epirubicin, cisplatin, and fluorouracil or capecitabine in patients with resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4-AIO): results from the phase 2 part of a multicentre, open-label, randomised phase 2/3 trial

  The Lancet Oncology · 2016 · 10.1016/s1470-2045(16)30531-9

• Sirolimus Use in Liver Transplant Recipients With Hepatocellular Carcinoma

  Transplantation · 2015 · https://doi.org/10.1097/tp.0000000000000965

• Survival of patients with initially unresectable colorectal liver metastases treated with FOLFOX/cetuximab or FOLFIRI/cetuximab in a multidisciplinary concept (CELIM study)

  Annals of Oncology · 2014 · 10.1093/annonc/mdu088

• Neoadjuvant chemoradiation therapy with gemcitabine/cisplatin and surgery versus immediate surgery in resectable pancreatic cancer

  Strahlentherapie und Onkologie · 2014 · 10.1007/s00066-014-0737-7

• Perioperative FOLFOX4 chemotherapy and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC 40983): long-term results of a randomised, controlled, phase 3 trial

  The Lancet Oncology · 2013 · 10.1016/s1470-2045(13)70447-9

• Radiofrequency ablation combined with systemic treatment versus systemic treatment alone in patients with non-resectable colorectal liver metastases: a randomized EORTC Intergroup phase II study (EORTC 40004)

  Annals of Oncology · 2012 · 10.1093/annonc/mds053

• A prospective randomised, open-labeled, trial comparing sirolimus-containing versus mTOR-inhibitor-free immunosuppression in patients undergoing liver transplantation for hepatocellular carcinoma

  BMC Cancer · 2010 · https://doi.org/10.1186/1471-2407-10-190

• Neoadjuvant Chemotherapy Compared With Surgery Alone for Locally Advanced Cancer of the Stomach and Cardia: European Organisation for Research and Treatment of Cancer Randomized Trial 40954

  Journal of Clinical Oncology · 2010 · 10.1200/jco.2009.26.6114

• Tumour response and secondary resectability of colorectal liver metastases following neoadjuvant chemotherapy with cetuximab: the CELIM randomised phase 2 trial

  The Lancet Oncology · 2009 · 10.1016/s1470-2045(09)70330-4

• Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial

  The Lancet · 2008 · 10.1016/s0140-6736(08)60455-9

• Adjuvant Chemotherapy With Gemcitabine vs Observation in Patients Undergoing Curative-Intent Resection of Pancreatic Cancer

  JAMA · 2007 · 10.1001/jama.297.3.267

• Liver transplantation for Budd–Chiari syndrome: A European study on 248 patients from 51 centres

  Journal of Hepatology · 2005 · https://doi.org/10.1016/j.jhep.2005.12.002

• Vascular Invasion and Histopathologic Grading Determine Outcome After Liver Transplantation for Hepatocellular Carcinoma in Cirrhosis

  Hepatology · 2001 · https://doi.org/10.1053/jhep.2001.23561

• Neurotoxicity of calcineurin inhibitors: impact and clinical management

  Transplant International · 2000 · 10.1111/j.1432-2277.2000.tb01004.x

• Neurotoxicity of calcineurin inhibitors: impact and clinical management

  Transplant International · 2000 · 10.1007/s001470050708

• Extended Resections for Hilar Cholangiocarcinoma

  Annals of Surgery · 1999 · 10.1097/00000658-199912000-00010

• Randomized Trial of Surgery Versus Surgery Followed by Adjuvant Hepatic Arterial Infusion With 5-Fluorouracil and Folinic Acid for Liver Metastases of Colorectal Cancer

  Annals of Surgery · 1998 · 10.1097/00000658-199812000-00006

• Liver tumors: comparison of MR imaging with Gd-EOB-DTPA and Gd-DTPA.

  Radiology · 1996 · 10.1148/radiology.200.1.8657946

• The Role of Liver Transplantation in Hepatobiliary Malignancy. A Retrospective Analysis of 95 Patients with Particular Regard to Tumor Stage and Recurrence

  Annals of Surgery · 1989 · 10.1097/00000658-198901000-00013

Current projects

No projects listed.